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Abstract 
Background: Clinical use of chemotherapeutic drug, cisplatin is limited by its toxicity and drug resistance. There-
fore, efforts continue for the discovery of novel combination therapies with cisplatin, to increase efficacy and reduce 
its toxicity. Here, we screened 16 medicinal plant extracts from Northeast part of India and found that leaf extract 
of Zanthoxylum armatum DC. (ZALE) induced cytotoxicity as well as an effect on the increasing of the efficiency of 
chemotherapeutic drugs (cisplatin, mitomycin C and camptothecin). This work shows detail molecular mechanism of 
anti-cancer activity of ZALE and its potential for combined treatment regimens to enhance the apoptotic response of 
chemotherapeutic drugs.
Results: ZALE induced cytotoxicity, nuclear blebbing and DNA fragmentation in HeLA cells suggesting apoptosis 
induction in human cervical cell line. However, the apoptosis induced was independent of caspase 3 activation and 
poly ADP ribose polymerase (PARP) cleavage. Further, ZALE activated Mitogen-activated protein kinases (MAPK) path-
way as revealed by increased phosphorylation of extracellular-signal-regulated kinases (ERK), p38 and c-Jun N-ter-
minal kinase (JNK). Inhibition of ERK activation but not p38 or JNK completely blocked the ZALE induced apoptosis 
suggesting an ERK dependent apoptosis. Moreover, ZALE generated DNA double strand breaks as suggested by the 
induction γH2AX foci formation. Interestingly, pretreatment of certain cancer cell lines with ZALE, sensitized the can-
cer cells to cisplatin and other chemotherapeutic drugs. Enhanced caspase activation was observed in the synergistic 
interaction among chemotherapeutic drugs and ZALE.
Conclusion: Purification and identification of the bio-active molecules from the ZALE or as a complementary treat-
ment for a sequential treatment of ZALE with chemotherapeutic drugs might be a new challenger to open a new 
therapeutic window for the novel anti-cancer treatment.
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Background
Despite early promising results, cancer treatment with 
modulators has not improved due to the emergence of 
drug resistance. This may be explained by the fact that 
there are alternate resistance mechanisms, controlled 
by different families of genes, such as those involved in 
apoptosis. Therefore, there is a need to develop new 
anticancer drugs and novel regimens that are capable of 
killing drug-resistant cancer cells. Understanding that 
the molecular mechanisms of chemo-resistance implicate 
several ways and genes, including genes associated with 
apoptosis, the studies of new chemotherapeutic drugs or 
new protocols for cancer treatment are important and 
needed.
Apoptosis is a mode of programmed cell death that is 
used by multicellular organisms to remove cell detach-
ment, cell shrinkage, chromatin condensation, DNA 
degradation, and plasma membrane blebbing [1]. Apop-
tosis may be caspase-dependent, or caspase-independent 
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pathways [2]. Regulation of apoptosis is of paramount 
importance in cancer biology because a large numbers 
of cancer cells are defective in the regulation of apopto-
sis [3]. Therefore, finding of new biologically active mol-
ecules that can activate the highly regulated apoptotic 
cell death in cancer cells could be an important issue to 
improve the cancer treatment.
Natural products have played an important role as 
sources of effective anti-cancer agents. More than 
60  % of drugs for cancer treatment are of natural ori-
gin, particularly derived from plants [4]. Additionally, 
secondary metabolites of plants are considered to be 
important sources of molecules with a great potential 
for chemotherapy [5]. Research in plants, therefore, 
represents an invaluable source for discovering of new 
substances and secondary metabolites. From approxi-
mately more than 300,000 plant species reported, only 
a small percentage has been the subject of phytochemi-
cal and biological activity studies [6]. Here we screen 
the medicinal plants from north eastern part of India 
and found that leaf extracts of Zanthoxylum armatum 
DC. (local name: Mukthrubi) induced apoptosis and 
also sensitized the cancer cells to chemotherapeutic 
drugs.
Zanthoxylum armatum DC. is an aromatic medici-
nal plant in the Rutaceae family, and the plant parts like 
leaves, stem, bark, fruits, seeds and roots possess medici-
nal properties and are used in indigenous medicine 
preparation against various diseases like asthma, bron-
chitis, indigestion, varicose veins, diarrhea, rheumatism, 
dyspepsia, cholera and toothache. The different extracts 
from the plant have different pharmacological activities 
such as antioxidative [7], anti-inflammatory [8, 9], anti-
microbial, insecticidal, larvicidal [10, 11], piscicidal [12], 
hepatoprotective [13], antitumor [14], and immunomod-
ulation activity [15]. Aqueous extract of Z. armatum 
induced cellular and nuclear damaged coupled with inhi-
bition of mitotic activity in plant [16].
The current study was undertaken to evaluate the 
cytotoxic and genotoxic potential of the crude methanol 
extract of Z. armatum leaves (ZALE) in human cervical 
cell line (HeLa) and to gain insight into the molecular 
mechanism(s) by which the extract exert the cytotoxicity 
and chemo sensitize the cancer cells.
Results
ZALE induced apoptosis in human cervical cancer cell line
To investigate the plants which induced cytotoxicity, 16 
medicinal plants from the Manipur, a Northeast part of 
India were screened. Five extracts, including ZALE show 
IC50 less than 80 μg/ml while the remaining 11 extracts 
show IC50 more than 80  μg/ml (Fig.  1a). In this paper 
we have selected ZALE for further study. Treatment 
of HeLa cells with 80  μg/ml of ZALE for 48  h showed 
marked morphological changes and cytotoxicity in dose 
dependent manner. Most of the cells were rounded up 
and detached from the tissue culture dish (Additional 
file 1: Figure S1). Determination of the number of viable 
cells in proliferation or cytotoxicity assays showed a dose 
dependent inhibition of cell proliferation of HeLa cells 
and the IC50 of the ZALE was approximately 60  μg/ml 
(Fig. 1b).
Necrosis and apoptosis are two well-described pathways 
of cell death. The end stages of apoptosis are often char-
acterized by the appearance of membrane blebbing, the 
appearance of highly condensed chromatin and activation 
of an endonucleolytic process, that leads to the cleavage 
of chromosomal DNA into oligosomal DNA that can be 
observed as a distinct laddering pattern on an ethidium 
bromide-stained agarose gel. To determine whether the 
cytotoxicity observed was due to apoptosis, the cells were 
stained with 4, 6-diamidino-2-phenylindole (DAPI) and 
observed under microscope. Similar to cell cytotoxic-
ity, increased micronuclei and nuclear ablation were also 
observed in the cells treated with ZALE (Fig. 1c). To fur-
ther confirm that ZALE treatment induced apoptosis, 
nucleosomal DNA fragmentation and single cell comet 
assay were analyzed. Fluorescent comets with varying 
length of “tails” and increased nucleosomal DNA fragmen-
tations were visible when HeLa cells were treated with dif-
ferent concentration of ZALE (Additional file 1: Figure S2 
and data not shown). Taken together, these data clearly 
suggest that ZALE induced apoptosis in HeLa cell line.
ZALE induced apoptosis is independent of caspase 3 
activation and PARP cleavage
Apoptosis can be classified into caspase-dependent or 
caspase-independent pathways. All caspases are syn-
thesized in cells as catalytically inactive zymogens and 
are activated by proteolytic cleavage. Activated caspases 
cleaved key cellular components that are required for 
normal cellular functions, including structural proteins 
in the cytoskeleton and nuclear proteins, such as DNA 
repair enzymes, including the enzyme PARP [17]. The 
cleavage of PARP by caspase is often used as a marker for 
caspase activity. To delineate the molecular mechanism 
of apoptosis induced by ZALE, we analyzed the caspase 
3 activation and PARP cleavage by immunoblotting. As 
expected, the etoposide treated positive control cells 
show caspase 3 activation and PARP cleavage (Fig. 2, lane 
4). However, ZALE treated cells did not show any caspase 
3 activation or PARP cleavage (Fig.  2). Similar results 
were observed when the cells were treated at shorter 
time points of 8, 16 and 24 h (Fig. 2, lane 2 and data not 
shown), suggesting for apoptosis without activating cas-
pase 3 and PARP cleavage.
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ZALE activates MAPK pathway
Recent literatures have shown MAPK pathway depend-
ent apoptosis without activating caspase 3 or PARP 
cleavage [18]. This prompted us to investigate if ZALE 
treated cells also activated MAPK pathways and induced 
apoptosis independent of caspase 3 activation and PARP 
cleavage. Immunoblot analysis of MAPK pathways acti-
vation using phosphorylated forms of JNK, ERK and p38 
show that none of the MAPK pathways were activated 
in 8  h; however all the MAPK pathways were activated 
in 16  h as determined by increased phosphorylation of 
ERK, JNK and p38 (Fig.  3). Maximum phosphorylation 
was found using anti-pERK (Fig.  3, Lane 3). Interest-
ingly, ZALE also activated p38 similar to the activation by 
chemotherapeutic drug, etoposide.
Roles of MAPK pathway in ZALE induced apoptosis
We have shown that ZALE activated MAPK pathways. 
Further, we wanted to investigate whether the ZALE 
induced apoptosis is due to the activation of MAPK 
pathways. Interestingly, the MEK1/2 inhibitor U0126, 
which inhibits MEK1/2 activity and thereby blocks 
ERK1/2 phosphorylation, completely abrogated the 
ZALE induced apoptosis and cell cytotoxicity. Cell were 
rescued from the anti-proliferative activity as well as cell 
death (Fig. 4a, b) suggesting that phosphorylated ERK1/2 
is important for ZALE induced apoptosis. The cell death 
was not inhibited by the JNK inhibitor, SP600125 and 
Fig. 1 Screening of apoptosis inducing plant extracts. a Graph showing efficacy of plant extracts screened for cytotoxicity. HeLa cells were treated 
with plant extracts (80 μg/ml) and the viable cells were measured with the Cell Titer 96 Proliferation Assay (Promega). b Graph showing the dose 
depedent inhibton of cell proliferation. Cells were treated either with DMSO or with the indicated concentration of ZALE and the viable cells were 
measured as above. The data represent the percentage growth compared with DMSO. c Left panel quantification of apoptotic nuclei observed 
in HeLa cells treated with either DMSO or ZALE with the indicted extract concentration for 48 h. Right panel representative DAPI stained images. 
Arrows indicate apoptotic fragmented nuclei
Fig. 2 ZALE failed to activate caspase 3. Immuoblot for the analysis 
of caspase3 activtion and PARP cleavage. HeLa cells were treated with 
DMSO (negative control), ZALE (60 μg/ml) or etoposide (Etp) for 
the indicated time. Total cell lysates were immunoblotted with the 
indicated antibodies. Etp treated sample was included as a positive 
control
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the p38 inhibitor, SB203580 (Fig.  4a, b). Inhibitions of 
ERK, JNK and p38 by their respective inhibitors, U0126, 
SP600125, SB203580 were confirmed by immunoblotting 
(Fig. 4c).
ZALE induced DNA damage
Histone H2AX was phosphorylated in response to DNA 
damages such as double strand breaks by γ-irradiation. 
Immuno-fluorescence analysis for γH2AX foci forma-
tion, observed an increased in γH2AX foci (more than 
five foci per cell) in ZALE treated HeLa cells in a dose 
dependent manner (Fig. 5) indicating generation of DNA 
double strand breaks. Interestingly, the amount of cell 
death was correlated with the number of the cells with 
γH2AX foci. When the cells were treated with a dose of 
60 μg/ml (IC50) of ZALE, half of the cells show γH2AX 
foci.
Synergistic interaction between ZALE 
and chemotherapeutic drugs
To investigate if any of the plant extracts screened in 
Fig.  1a, can enhanced the apoptosis induced by the 
chemotherapeutic drugs, we pretreated HeLa cells with 
low dose (15  μg/ml) of the plant extracts for 16  h and 
then exposed to chemotherapeutic drug, cisplatin for 
48 h. Cell proliferation assay show that two of the plant 
extracts exhibit greater cell death in combination treat-
ment, compared to the individual treatment. One of them 
is ZALE which showed 70  % more cell killing (Fig.  6a). 
This data suggest that ZALE also augment chemothera-
peutic drugs induced apoptosis.
Caspase activation appears to be a common pathway in 
apoptosis induced by chemotherapeutic drugs. Because 
ZALE augment chemotherapeutic drugs induced apopto-
sis, we sought to examine the mechanism of this interac-
tion by measuring caspase 3 activation by their cleavage. 
As shown in Fig.  6b, while ZALE alone cannot activate 
caspase 3, combination of ZALE with cisplatin resulted 
in enhanced caspase 3 activation. This data suggest that 
ZALE enhanced the apoptosis-inducing potential of 
chemotherapeutic drugs by triggering caspase-3 acti-
vation. Similar enhanced apoptosis was observed with 
other chemotherapeutic drugs such as mitomycin C and 
camptothecin (Fig.  6c). The potential synergistic effects 
were investigated using low doses of ZALE and chemo-
therapeutic drugs. Analysis of the combination effects in 
HeLa cells showed that Q values of all were more than 
1.15, as shown in Table  1. The results showed that the 
combination of ZALE and chemotherapeutic drugs had 
an apparent effect on HeLa cells survival, and they had 
a synergistic effect. Analysis of the combination effects 
of ZALE and cisplatin in different cancer cell lines show 
that the synergistic effect is cancer cell type dependent. 
The synergistic effect was observed in cervical (HeLa), 
prostate (LNCaP), bone (U2OS) cancer cell lines but not 
in lungs cancer (A549) cell line (Table 2).
Discussion
The present experiments were designed to screen 16 
medicinal plants for cytotoxicity and enhancing the effi-
cacy of chemotherapeutic drugs. Here, we show that the 
crude ZALE induced cytotoxicity and also enhanced the 
effect of chemotherapeutic drugs. Evaluation of DAPI 
stained nuclei of HeLa cells after treating with ZALE 
show DNA fragmentation and apoptotic bodies forma-
tion (Fig. 1c). The amount of apoptotic bodies formation 
was in dose dependent manner; suggesting that ZALE 
induced apoptosis in HeLa cells and the IC50 was 60 μg/
ml. Apoptotic effect was further confirmed by DNA frag-
mentation assay on agarose gel electrophoresis and by 
single cell gel electrophoresis. Extracts from other Zan-
thoxylum species have shown to possess cytotoxic and 
genotoxic effects. Zanthoxylum americanum extract has 
shown cytotoxicity [19] and Rutaceline (a benzophenan-
thridine) isolated from Zanthoxylum madagascariense 
has shown antiproliferative effect, alteration of cell cycle, 
apoptosis, and genotoxic damage in a human intestinal 
cancer cell line Caco-2 [20].
Our results also show that ZALE activated MAPK 
pathway and ERK activation was maximum as com-
pared to p38 or JNK activation (Fig.  3). ERK activa-
tion was essential for ZALE induced apoptosis. Further, 
there was no activation of caspase 3 and PARP cleavage 
in the ZALE induced apoptosis in HeLa cells (Fig.  2). 
Fig. 3 Analysis of MAPK pathway activation by ZALE. Immuoblot 
showing MAPK pathway activtion. HeLa cells were treated with ZALE 
(60 μg/ml) for 8 and 16 h and total cell lysates were immunoblotted 
with the indicated MAPK pathway antibodies. DMSO and Etoposide 
(Etp) treated samples were included as negative and positive
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Such caspase and PARP activation independent apop-
tosis was reported in rat adrenal pheochromocytoma 
PC12 cells while treated with α-eleostearic acid which is 
a conjugated trienoic fatty acid that occurs in the seeds 
of plants such as Vernicia spp. Such apoptosis is associ-
ated with superoxide production and the prolonged ERK 
Fig. 4 ZALE induced ERK dependent apoptosis. a ZALE induced cytotoxicity to HeLa cells is ERK dependent. HeLa cells were treated with DMSO, 
ZALE, U0126 (ERK inhibitor), SP600125 (JNK inhibitor), or combination of inhibitor and ZALE. For combination treatment, cells were pretreated with 
the inhibitors 2 h prior to the treatment with ZALE (60 μg/ml). After 48 h viable cells were measured. The data represent the percentage growth 
compared with DMSO treated cells and show 1 representative result of 3 independent experiments with standard deviations. b Quantification of 
apoptotic nuclei observed after DAPI staining in the HeLa cells treated with either DMSO or ZALE or the MAPK inhibitors-ZALE combination for 48 h. 
c Immunblot showing the inhibition of activation of ERK, p38 and JNK by their respective inhibitors. Cells were treated with D (DMSO), Z (ZALE) or Z 
and the specific inhibitors
Fig. 5 ZALE induced γH2AX foci formation. Left panel representative images showing γH2AX foci in HeLa cells treated with ZALE or the DMSO only. 
Right panel quantification of the number of cells with more than 5 foci in the cells treated with different doses of ZALE as indicated or DMSO treated 
control. HeLa cells were treated with the indicated concentration of ZALE for 24 h and the cells were fixed and the γH2AX foci were analyzed by 
immunofluorescent using anti-γH2AX antibody
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phosphorylation and are not associated with molecules 
such as Bax, Cytochrome c caspase 3 and PARP [18].
ERK is a key regulator of apoptosis and the apoptotic 
cell death induced by several drugs such as camptothecin 
and N-methyl-N′-nitro-N-nitrosoguanidine (MNNG) 
can be blocked by MEK1/2 inhibitors (U0126). ERK func-
tion in response to DNA damage and ERK activation was 
observed in response to cisplatin in ovarian cancer cells 
[21]. We did not observe any MAPK activation in early 
time point (8 h). However, strong MAPK activation was 
observed at later time (18 h), indicating that the phenom-
enon might be due to the intrinsic cellular changes such 
as DNA damage. Interestingly, ZALE induced γH2AX 
foci formation which indicates DNA double strand 
breaks (Fig. 5). Degree of ERK activation correlated with 
the intensity of DNA damage. Tumor suppressor protein, 
p53 and ERK activation cooperate with DNA damage-
induced cell cycle arrest and apoptosis [22]. Speculatively, 
ZALE might contain phytoactive compound(s) which 
induced DNA double strand breaks that activated MAPK 
pathway. Nevertheless, γH2Ax foci formation is also an 
indication of early apoptosis. It may also be formed con-
currently with the initiation of DNA double-stranded 
breaks resulting from the apoptotic endonuclease acti-
vation and is essential for apoptosis that induced DNA 
fragmentation [21]. Interestingly, ZALE also enhanced 
the apoptosis inducing potential of chemotherapeutic 
drugs and the increased apoptosis was associated with 
increased caspase activation. It is well known that p38 is 
required for chemotherapeutic drugs induced apoptosis 
Fig. 6 ZALE enhanced chemotherapeutic drugs induced apoptosis. a Screening of medicinal plants that increased the cisplatin induced cyto-
toxicity. HeLa cells were pretreated with the plant extracts (15 μg/ml) for 16 h before treatment with cisplatin (3 μM) for 72 h. Viable cells were 
measured. b Immunoblot showing that ZALE pretreatment increased cisplatin.induced caspase activation HeLa cells were treated as denoted and 
the cells were lysed and immunoblotted with caspase 3 antibody. c Sequential treatment of ZALE with chemotherapeutic drugs show synergistic 
apoptosis. HeLa cells were pre-treated with low dose (15 μg/ml) of ZALE for 16 h and then treated with 100 ng/ml of mitomycin C (MMC) or 10 ng/
ml of camptothecin (CPT) or cisplatin (3 μM) for 72 h. Viable cells were measured as described else where asterisk indicates Q value more than 1.15 
according to Jin’s formula
Table 1 Synergistic effect of ZALE combined with different 
drugs on HeLa cells analyzed by Jin’s formula (value listed 
in the table)
According to Jin’s formula,  < 0.85 indicates antagonism, 0.85 ≤  < 1.15 indicates 
additive effects, and  ≥ 1.15 indicates synergism
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[23]. Since ZALE also induced p38 activation, it is possi-
ble that the enhanced apoptotic potential of chemothera-
peutic drugs may be due to the activation of p38 by the 
ZALE (Fig. 3, lane 3).
Synergistic effect of ZALE and cisplatin were observed 
in various cancer cell lines (cervical, prostate, osteosar-
coma) except A549 which is a lungs cancer cell line. Inter-
estingly, all the cell lines which have shown synergistic 
combination effects, harbour wild type p53 while the A549 
which did not show combination effects have mutant p53, 
suggesting that p53 might be essential for the increased 
apoptosis observed in the combination treatment.
The crude extract used is not of single chemical enti-
ties. Plants produced complex mixtures of second-
ary metabolites consisting of alkaloids, polyphenols, or 
diverse terpenoids and the extract will be a mixture of all 
the secondary metabolites [24]. Therefore, the biological 
activities of ZALE may be results of each independent 
constituent or an additive effect.
The properties of ZALE described here lead us to pro-
pose a model of its mechanism of action (summarized 
schematically in Fig.  7). Firstly, ZALE induced DNA 
double strand breaks as shown by increased γH2AX foci 
formation (Fig. 5) and the damaged DNA activated ERK 
pathway. Prolong activation of ERK leads to the release 
of apoptosis inducing factor (AIF) and thereby inducing 
apoptosis in a caspase independent pathway. Secondly, 
treatments of ZALE along with the chemotherapeutic 
drugs induced enhanced caspase activation that plays 
a significant role in the synergistic interaction among 
chemotherapeutic drugs and ZALE. Purification, identi-
fication and characterization of the bioactive compounds 
present in ZALE or administration of ZALE along with 
the chemotherapeutic drugs will open a new therapeutic 
window for cancer treatment.
Conclusion
In conclusion, we have shown that crude ZALE induced 
apoptosis in human cervical cell line in an ERK depend-
ent pathway; independent of caspase activation and 
PARP cleavage. ZALE also induced DNA damage and 
enhanced the chemotherapeutic drugs induced apopto-
sis by increasing caspase activation. We have shown the 
Table 2 Table showing the consequences of  combination 
treatment of  ZALE and  cisplatin in  different tumor cell 
lines
+ Synergistic effect observed and − synergistic effect not observed





U2OS Bone (osteosarcoma) +
Fig. 7 Speculative mechanism of ZALE mediated cell death. ZALE induced DNA damage and ERK activation. Activation of ERK released AIF that 
lead to apoptosis in a caspase independent manner. Alternatively, sequential treatment of ZALE with chemotherapeutic drugs enhanced caspase 
activation, leading to caspase dependent apoptosis
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potential of combining chemotherapeutic drugs with 




The study included 16 different plants from Manipur 
State of India and the leaf extracts were prepared follow-
ing the protocol described earlier by Nostro et  al. [24]. 
Briefly, the leaves were washed with pure water and dried 
at room temperature. The dried leaves were processed 
as coarse powder. Powdered material (10  g) was dis-
solved in methanol (100 mL) and incubated at 25 ± 1 °C 
for 48  h with agitation. The organic extract was filtered 
with Whatman filter paper No.1, concentrated by freeze 
drying. The dried extracts were dissolved in DMSO at 
0.1 g/ml concentration and stored frozen at −20 °C until 
analysis.
Antibodies and inhibitors
The antibodies for ERK, phospho-ERK, JNK, phospho 
JNK, p38, phospho-p38, cleaved caspase-3 and cleaved 
PARP-1 were purchased from Cell Signaling. β-actin 
(Santa Cruz Biotechnology) and γH2AX (Upstate) 
were also procured. The inhibitors, U0126 (Cell Signal-
ling), SB203580 and SP600125 (Abcam) were also pur-
chased. Working concentration for U0126, SB203580 and 
SP600125 are 10, 20 and 20 μM respectively.
Chemicals
All the chemicals were purchased from Sigma Aldrich 
(USA). Mitomycin C (MMC) was dissolved in 70 % etha-
nol to a stock concentration of 250 ng/μL. Camptothecin 
(CPT) was dissolved in DMSO to a stock concentration 
of 10 mM.
Cell culture
In order to evaluate anti-cancer activities of organic 
extract of Zanthoxylum armatum. DC, we have used dif-
ferent kinds of cancer cells. Within these cells we have 
included LNCaP, U2OS, A549 and HeLa. The LNCaP 
cells are human prostate cancer cells, highly resistant 
to human fibroblast interferon, and show an aneuploid 
(modal number, 76 to 91) human male karyotype with 
several marker chromosomes [25]. The U2OS cells are 
osteosarcoma epithelial cells with highly altered, chro-
mosome counts in the hypertriploid range involving 
the same chromosomes (N1, N7, N9, and N11 particu-
larly). The A549 cells are adenocarcinomic human alveo-
lar basal epithelial cells. This is a hypotriploid human cell 
line with the modal chromosome number of 66, 64, 65, 
and 67 chromosome counts at relatively high frequencies. 
Finally the Hela cells are cells derived from cervical can-
cer cells with 100 % aneuploidy. There is a small telocen-
tric chromosome in 98 % of the cells [26].
All the cells were purchased from the National Centre 
for Cell Science (Pune, India). The cells were maintained 
at 37 °C, 5 % CO2 in RPMI-1640 media supplement with 
10 % fetal bovine serum (FBS).
Evaluation of cell viability and apoptosis assay
HeLa cells were seeded in 96-well tissue culture plates, at 
a density of 5 × 103 cells/well and incubated for 16 h to 
adhere the cells. The cells were then exposed to increas-
ing concentrations of ZALE (15–90 μg/ml) for 48 h. and 
viable cells were assayed using CellTiter 96 AQueous 
One Solution Reagent (Promega) following the protocol 
provided by the manufacturer. For combination treat-
ment, cells were pre-treated with the plant extracts for 
16 h prior to the treatment with chemotherapeutic drugs.
For apoptosis assay, the cells were stained with 4, 
6-diamidino-2-phenylindole (DAPI) and apoptotic cells 
are indicated by small, condensed nuclei. The cells were 
plated onto sterile coverslips in a 35 mm dish. After treat-
ment, the floating cells were pelleted by centrifuging at 
1100 rpm for 5 min. The cells were washed with PBS for 
5 min. After aspirating the wash, the cells were permeabi-
lized with 1 ml permeabilization buffer (0.5 % tritonX100 
in PBS) for 3 min. The cells were washed and fixed in 1 ml 
of 2 % paraformaldehyde in PBS Buffer for 10 min. The 
cells were washed and mounted the coverslips on slides 
with mounting medium, ProLong Gold Antifade Reagent 
with DAPI (Invitrogen). The coverslip were glued using 
clear nail polish. Apoptotic cells can be observed with a 
fluorescent microscope.
Evaluation of synergetic effect by Jin’s formula
Synergetic effect of the combination of ZALE and chemo-
therapeutic drugs was analyzed by Jin’s formula. The for-
mula is Q =  Ea + b/(Ea + Eb – Ea × Eb), where Ea + b, 
represented the average effects (inhibition rate) of the 
combination treatment. and are the inhibition rate of sin-
gle treatment of ZALE only or chemotherapeutic drug 
only. In this method,  < 0.85 indicates antagonism, 0.85 ≤  
Q < 1.15 indicates additive effects, and   Q ≥ 1.15 indicates 
synergism.
Immunofluorescent staining
For detection of γH2AX, cells were fixed with 4 % para-
formaldehyde for 10 min. Cells were then permeabilized 
with PBS containing 0.5 % Triton X-100 for 5 min at RT. 
γH2AX foci were determined by immunofluorescence 
microscopy as described previously using Ser139 rabbit 
polyclonal antibodies (Upstate) [27].
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Western blot analysis
The cells were treated with the extract and the cells were 
lysed directly with 2X Laemmli sample buffer and the 
samples were resolved by SDS-PAGE on 5–12  % gradi-
ent gels and transferred onto PVDF membranes. The 
membranes were blocked with 5 % non-fat milk for 1 h 
and incubated with primary antibodies (1:2000 dilu-
tion) at 4 °C overnight and then with secondary antibody 
(1:6000 dilution) for 1 h at room temperature. The blots 
were detected using chemiluminescent ECL system (GE 
Healthcare).
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